1.
Pakistan Journal of Otolaryngology-Head and Neck Surgery. 1991; 7 (1): 23-5
in English
| IMEMR
| ID: emr-119090
ABSTRACT
Thirty patients with advanced malignancy and on treatment with Cisplatin were assessed for impairment in sense of smell [olfaction]. Nine [30%] cases were found to have some degree of anosmia. Olfaction returned to normal within 3-4 months following discontinuation of Cisplatin only in patients with mild degree of loss